Characterization and biocompatibility of injectable microspheres-loaded hydrogel for methotrexate delivery.
Injectable thermosensitive hydrogels have widely been studied as drug delivery systems for their minimally invasive administration and localized drug release. However, burst drug release limits clinical applications of such hydrogels. A double-component injectable formulation (microspheres-loaded hydrogel, CMs-CS-HG) was thus fabricated to eliminate the limitation. Gelation temperature, gelation time, complex viscosity and syringeability tests for CMs-CS-HG demonstrated excellent injectability. After injection, the drug-loaded chitosan-based microspheres (CMs) were localized within the hydrogel, leading to localized drug release. Moreover, CMs-CS-HG had good hemocompatibility and histocompatibility, and had non-genotoxicity and non-cytotoxicity to Kunming mice. In addition, both in vitro and in vivo methotrexate (MTX) releasing efficiencies were evaluated, demonstrating long-term sustained MTX release from MTX-loaded CMs-CS-HG. These results showed the double-component CMs-CS-HG not only maintained good injectability and biocompatibility but also prolonged drug-releasing time in comparison with the single-component CS-HG or CMs, suggesting that CMs-CS-HG may be a promising drug delivery system.